An artificial intelligence-backed virtual biotech company predicted drug trial success and independently designed a lung cancer therapy that was later validated in trials.
An artificial intelligence-backed virtual biotech company predicted drug trial success and independently designed a lung cancer therapy that was later validated in trials.